Last edition
News about
Medicamen debuts in domestic pharma
The company has entered the cardio-vascular & Diabetes (CVD) business
Medhini Group signs MOUs with multiple India-based cleanroom experts
Medhini is using these two companies to uplift programmes for pharmaceutical manufacturing in Malaysia
Supriya Lifescience appoints Rajeev Kumar Jain as CEO
He has over 35+ years of rich functional experience in the manufacturing domain of bulk drugs, intermediate and API
Zydus Lifesciences bags US FDA approval for Sildenafil for Oral Suspension
The drug will be manufactured at the group’s formulation manufacturing facility at Baddi, Himachal Pradesh
Lupin gets EIR from US FDA for its Ankleshwar facility
The inspection of the facility was conducted from August 16-19, 2022
Zydus Lifesciences' Ahmedabad unit under USFDA observation
The inspection was conducted between September 23 to September 29, 2022
Piramal Pharma appoints Vibha Paul Rishi to its Board of Directors
Rishi is a marketing professional and has held global leadership positions across branding, strategy, innovation and human capital
Lupin's Tarapur facility receives warning letter from US FDA
The company believes that the warning letter will not affect supply disruptions or current revenues from this facility's operations
Jiuzhou Pharma to buy Sandoz finished drugs plant in Zhongshan for $15.1 M
The Chinese firm also plans to refurbish and expand the facility, altogether redirecting $18.5 million of capital to the Sandoz project.<br />
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy